Literature DB >> 3526086

Correlation between insulin clearance and insulin responsiveness: studies in normal, obese, hyperthyroid, and Cushing's syndrome patients.

P Cohen, N Barzilai, D Barzilai, E Karnieli.   

Abstract

Insulin clearance and secretion determine the plasma insulin concentration. To elucidate the significance of these parameters in man, we employed the euglycemic insulin clamp technique to measure insulin sensitivity, insulin responsiveness, and insulin clearance, and we calculated the basal insulin delivery rate. In 27 patients (six normal, six obese, ten hyperthyroid, and five with Cushing's syndrome), insulin was infused at rates of 0.3, 1, 3, or 10 mU/Kg/min, and insulin concentration and glucose utilization were measured. C-peptide concentrations were measured before and during insulin infusion and decreased significantly, indicating a reduction of endogenous insulin secretion to 62% of basal in normals and a similar reduction in the other groups. Maximal responsiveness to insulin was a glucose utilization rate of 450 +/- 20 mg/min/m2 in normals, unchanged in obese, 42% increased in hyperthyroid, and 34% decreased in Cushing's syndrome patients. Sensitivity to insulin was decreased in all three abnormal groups. Insulin clearance rates were 1,050 +/- 80 mL/min/m2 for normals, not significantly changed in obese, 45% increased in hyperthyroid, and 33% decreased in Cushing's syndrome patients. All three abnormal groups showed hyperinsulinemia compared to normal. The basal insulin delivery rates were calculated as 7.0 +/- 0.3 mU/min/m2, with a threefold increase in obese and in hyperthyroid and no significant change in Cushing's syndrome patients. Insulin clearance correlated well with insulin responsiveness (r = .65, P less than 0.001), but poorly with insulin sensitivity (r = .36).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3526086     DOI: 10.1016/0026-0495(86)90242-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin.

Authors:  N Barzilai; P H Groop; L Groop; R A DeFronzo
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

2.  Yangxin Tongmai Formula ameliorates impaired glucose tolerance in children with Graves' disease through upregulation of the insulin receptor levels.

Authors:  Yan-Hong Luo; Min Zhu; Dong-Gang Wang; Yu-Sheng Yang; Tao Tan; Hua Zhu; Jian-Feng He
Journal:  Acta Pharmacol Sin       Date:  2017-11-23       Impact factor: 6.150

Review 3.  Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.

Authors:  P O'Connor; J Feely
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

4.  Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults.

Authors:  P A Velasquez-Mieyer; P A Cowan; K L Arheart; C K Buffington; K A Spencer; B E Connelly; G W Cowan; R H Lustig
Journal:  Int J Obes Relat Metab Disord       Date:  2003-02

5.  Diabetogenic effect of cyclosporin.

Authors:  J J Bending; C S Ogg; G C Viberti
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

6.  In vivo insulin action in hepatocellular and cholestatic liver cirrhosis.

Authors:  N Barzilai; P Cohen; E Karnieli; R Enat; O Epstein; J Owen; N McIntyre
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

7.  Acute Effects of Insulin on Cardiac Function in Patients with Diabetes Mellitus: Clinical Applicability and Feasibility.

Authors:  Deeb Daoud Naccache; Sergey Yalonetsky; Ronen Bar-Yoseph
Journal:  Int J Endocrinol       Date:  2020-03-17       Impact factor: 3.257

8.  A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c.

Authors:  Hirofumi Zempo; Su-Jeong Kim; Noriyuki Fuku; Yuichiro Nishida; Yasuki Higaki; Junxiang Wan; Kelvin Yen; Brendan Miller; Roberto Vicinanza; Eri Miyamoto-Mikami; Hiroshi Kumagai; Hisashi Naito; Jialin Xiao; Hemal H Mehta; Changhan Lee; Megumi Hara; Yesha M Patel; Veronica W Setiawan; Timothy M Moore; Andrea L Hevener; Yoichi Sutoh; Atsushi Shimizu; Kaname Kojima; Kengo Kinoshita; Yasumichi Arai; Nobuyoshi Hirose; Seiji Maeda; Keitaro Tanaka; Pinchas Cohen
Journal:  Aging (Albany NY)       Date:  2021-01-19       Impact factor: 5.955

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.